.FDA refuses psychedelic MDMA-assisted treatment for PTSD NBC NewsF.D.A. Downtrends to Permit MDMA Treatment, Seeking Additional Research The New York TimesFDA Denies Ecstasy-Based Medication The Commercial JournalFDA refuses to authorize unique MDMA treatment to alleviate post-traumatic stress disorder, with ask for additional hearing records CNNFDA turns down to begin with psychedelic to address post-traumatic stress disorder, requiring additional research study The Washington Post.